NEWS

Karolinska Development and Kurma Biofund to enter strategic partnership

Karolinska Development AB and Kurma Biofund have entered into a strategic partnership, with the purpose to identify co-investment opportunities in the life science area in the Nordic region and other selected parts of Europe.

The Karolinska Development and Kurma Biofund combination will increase the possibilities for early life science investments in world class science. The strategic Karolinska Development and Kurma Biofund partnership will further contribute to cross European investments.

Conny Bogentoft, CEO Karolinska Development; “We are excited to broaden our co-investor network for early stage financing. With Kurma we also add a broader dealflow outside of Scandinavia and add a competent partner to our network.”

Thierry Laugel, joint Managing Partner Kurma Biofund; “With Karolinska Development, Kurma is proud to add such an eminent group to the very selective network of partners around Europe. We are currently looking at a number of co- investment opportunities that would clearly exemplify the complementarities and synergies between our two groups.”

For more information >>>

HEADLINES

2011-12-26
KARO BIO ENTERS COLLABORATION WITH PFIZER
KARO BIO ENTERS COLLABORATION WITH PFIZER TO DISCOVER AND DEVELOP INNOVATIVE DRUGS FOR AUTOIMMUNE DISEASES

2011-12-02
Halo Genomics Acquired by Agilent Technologies

2011-11-21
Uppsala get Sweden’s first PET-MRI equipment

2011-10-12
Millions of new regulatory elements found in human genome

2011-09-22
Xbrane Bioscience wins Incubator Export Challenge 2011
For their innovative product portfolio to solve big problems, Xbrane won a national competition arranged by Swedish-American Chambers of Commerce, including a prize contributing to Xbrane's establishment on the US market.

2011-05-30
Extended coverage and new outfit for the gateway Tools of Science
A new design for Tools of Science was launched 27th of May and 11 new facilities from Uppsala became members of the web platform.

2011-04-05
World record in DNA analysis
To date, scientists have been limited to running a small number of DNA samples at a time at a cost of SEK 100,000 per sample. KTH researchers have now come up with a new method which means that 5,000 samples can be run simultaneously for the same price. This cuts the cost per test result ...

2011-03-01
The Swedish Medical Products Agency in international collaborations for sustainability
With a strong position as a “Centre of Regulatory Excellence” within Europe, the MPA is taking part in collaborations outside the union. The MPA has during the last year (2010) been involved in over 110 international organizations, comittees and projects.

2011-02-18
Doxa signing exclusive global distribution contract
The Swedish dental company Doxa has signed an exclusive global distribution contract for Ceramir Crown & Bridge dental cement with Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of health care products and services to office-based practitioners.

2011-01-11
New CEO in Flemingsberg
Bjorn Varnestig takes his role as CEO of the new Foundation Flemingsberg Science. The foundation will give Flemingsberg a stronger role in the region within the life science. It focuses particularly on creating more knowledge-intensive business.